BMJ  2004;328:534-535 (6 March), doi:10.1136/bmj.328.7439.534

Editorial

Treating malaria in Africa

Sulfadoxine-pyrimethamine may still have a future despite reports of resistance

The first 150 words of the full text of this article appear below.

For many years the treatment of malaria in Africa has relied on chloroquine, sulfadoxine combined with pyrimethamine, and quinine, with the latter being used mainly to treat severe cases. Quinine remains efficacious, but chloroquine and sulfadoxine-pyrimethamine are failing, and this is leading to an increase in mortality from malaria especially in East Africa.^{1 2}

Although resistance to chloroquine was first detected on the east coast of Africa in 1977, the drug has provided effective treatment for malaria for much of Africa for over 20 years.^{3 4} Unfortunately this is unlikely to be the case for sulfadoxine-pyrimethamine, the combination adopted by several African countries as the first line treatment for malaria when chloroquine has failed. Systematic surveillance for resistance to malaria drugs and the results of trials of new drugs or drug combinations that could be used to replace chloroquine or sulfadoxine-pyrimethamine are showing a worryingly high level of resistance to sulfadoxine-pyrimethamine across . . . [Full text of this article]

Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT (brian.greenwood@lshtm.ac.uk)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Article

Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study

Christopher V Plowe, James G Kublin, Fraction K Dzinjalamala, Deborah S Kamwendo, Rabia A G Mukadam, Phillips Chimpeni, Malcolm E Molyneux, and Terrie E Taylor
BMJ 2004 328: 545. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Oyakhirome, S., Issifou, S., Pongratz, P., Barondi, F., Ramharter, M., Kun, J. F., Missinou, M. A., Lell, B., Kremsner, P. G. (2007). Randomized Controlled Trial of Fosmidomycin-Clindamycin versus Sulfadoxine-Pyrimethamine in the Treatment of Plasmodium falciparum Malaria. Antimicrob. Agents Chemother. 51: 1869-1871 [Abstract] [Full text]  

Online poll

Find out more >>